BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25939351)

  • 1. Successful Pregnancies with Thiopurine-Allopurinol Co-Therapy for Inflammatory Bowel Disease.
    Sheikh M; Nelson-Piercy C; Duley J; Florin T; Ansari A
    J Crohns Colitis; 2015 Aug; 9(8):680-4. PubMed ID: 25939351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease.
    Jharap B; de Boer NK; Stokkers P; Hommes DW; Oldenburg B; Dijkstra G; van der Woude CJ; de Jong DJ; Mulder CJ; van Elburg RM; van Bodegraven AA;
    Gut; 2014 Mar; 63(3):451-7. PubMed ID: 23424097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease.
    Ansari A; Patel N; Sanderson J; O'Donohue J; Duley JA; Florin TH
    Aliment Pharmacol Ther; 2010 Mar; 31(6):640-7. PubMed ID: 20015102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease.
    Hoentjen F; Seinen ML; Hanauer SB; de Boer NK; Rubin DT; Bouma G; Harrell LE; van Bodegraven AA
    Inflamm Bowel Dis; 2013 Feb; 19(2):363-9. PubMed ID: 22605661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol.
    Smith MA; Blaker P; Marinaki AM; Anderson SH; Irving PM; Sanderson JD
    J Crohns Colitis; 2012 Oct; 6(9):905-12. PubMed ID: 22386736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allopurinol enhanced thiopurine treatment for inflammatory bowel disease: safety considerations and guidelines for use.
    Min MX; Weinberg DI; McCabe RP
    J Clin Pharm Ther; 2014 Apr; 39(2):107-11. PubMed ID: 24438369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose thiopurine with allopurinol co-therapy overcomes thiopurine intolerance and allows thiopurine continuation in inflammatory bowel disease.
    Vasudevan A; Beswick L; Friedman AB; Moltzen A; Haridy J; Raghunath A; Sparrow M; van Langenberg D
    Dig Liver Dis; 2018 Jul; 50(7):682-688. PubMed ID: 29525182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of allopurinol and low-dose thiopurine combination therapy on the activity of three pivotal thiopurine metabolizing enzymes: results from a prospective pharmacological study.
    Seinen ML; van Asseldonk DP; de Boer NK; Losekoot N; Smid K; Mulder CJ; Bouma G; Peters GJ; van Bodegraven AA
    J Crohns Colitis; 2013 Nov; 7(10):812-9. PubMed ID: 23317929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiopurine Optimization Through Combination With Allopurinol in Children With Inflammatory Bowel Diseases.
    Serpico MR; Maltz R; Crandall W; Bricker J; Dotson JL; Kim SC; Boyle B
    J Pediatr Gastroenterol Nutr; 2018 Sep; 67(3):341-345. PubMed ID: 29601433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-life Intercept Cohorts: Effect of Allopurinol Comedication?
    Meijer B; Seinen ML; van Egmond R; Bouma G; Mulder CJJ; van Bodegraven AA; de Boer NKH
    Inflamm Bowel Dis; 2017 Nov; 23(11):2011-2017. PubMed ID: 28617756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Optimized thiopurine treatment in chronic inflammatory bowel disease].
    Kiszka-Kanowitz M; Theede K; Nielsen AM
    Ugeskr Laeger; 2015 Jun; 177(26):1253-5. PubMed ID: 26550625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of using allopurinol co-therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease.
    Ansari A; Elliott T; Baburajan B; Mayhead P; O'Donohue J; Chocair P; Sanderson J; Duley J
    Aliment Pharmacol Ther; 2008 Sep; 28(6):734-41. PubMed ID: 19145729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study).
    Friedman AB; Brown SJ; Bampton P; Barclay ML; Chung A; Macrae FA; McKenzie J; Reynolds J; Gibson PR; Hanauer SB; Sparrow MP
    Aliment Pharmacol Ther; 2018 Apr; 47(8):1092-1102. PubMed ID: 29468701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized clinical trial: a pilot study comparing efficacy of low-dose azathioprine and allopurinol to azathioprine on clinical outcomes in inflammatory bowel disease.
    Kiszka-Kanowitz M; Theede K; Mertz-Nielsen A
    Scand J Gastroenterol; 2016 Dec; 51(12):1470-1475. PubMed ID: 27686002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study.
    Coelho J; Beaugerie L; Colombel JF; Hébuterne X; Lerebours E; Lémann M; Baumer P; Cosnes J; Bourreille A; Gendre JP; Seksik P; Blain A; Metman EH; Nisard A; Cadiot G; Veyrac M; Coffin B; Dray X; Carrat F; Marteau P;
    Gut; 2011 Feb; 60(2):198-203. PubMed ID: 21115547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy.
    Hutson JR; Matlow JN; Moretti ME; Koren G
    J Obstet Gynaecol; 2013 Jan; 33(1):1-8. PubMed ID: 23259868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine.
    Sparrow MP; Hande SA; Friedman S; Lim WC; Reddy SI; Cao D; Hanauer SB
    Aliment Pharmacol Ther; 2005 Sep; 22(5):441-6. PubMed ID: 16128682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Thiopurines During Conception and Pregnancy Is Not Associated With Adverse Pregnancy Outcomes or Health of Infants at One Year in a Prospective Study.
    Kanis SL; de Lima-Karagiannis A; de Boer NKH; van der Woude CJ
    Clin Gastroenterol Hepatol; 2017 Aug; 15(8):1232-1241.e1. PubMed ID: 28342949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Getting the best out of thiopurine therapy: thiopurine S-methyltransferase and beyond.
    Fong SC; Blaker PA; Arenas-Hernandez M; Marinaki AM; Sanderson JD
    Biomark Med; 2015; 9(1):51-65. PubMed ID: 25605455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of pregnancies fathered by inflammatory bowel disease patients exposed to thiopurines.
    Teruel C; López-San Román A; Bermejo F; Taxonera C; Pérez-Calle JL; Gisbert JP; Martín-Arranz M; Ponferrada A; Van Domselaar M; Algaba A; Estellés J; López-Serrano P; Linares PM; Muriel A
    Am J Gastroenterol; 2010 Sep; 105(9):2003-8. PubMed ID: 20700117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.